The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Book Review
PreviousPrevious
Volume 360:550-551 January 29, 2009 Number 5

Antimicrobial Resistance: Problem Pathogens and Clinical Countermeasures

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
(Infectious Disease and Therapy. 48.) Edited by Robert C. Owens, Jr., and Ebbing Lautenbach. 492 pp., illustrated. New York, Informa Healthcare, 2008. $299.95. ISBN 978-0-8247-2941-7.

The antimicrobial era began about 75 years ago. Although it is far from over, it is being increasingly challenged by the emergence of resistant microorganisms. Antimicrobial resistance is the inevitable result of Darwinian evolution — natural selection and survival of the fittest. The emergence of resistance has been accelerated by the excessive use of antibiotics in conjunction with the remarkable genetic plasticity of microorganisms.

There is a close association between nosocomial infections and antibiotic use. Antimicrobial drugs can be helpful in the management of infectious complications of invasive procedures, immunosuppression, and aging, but they can have adverse side effects and . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.